The other SubB2M test is an SPR technology (surface plasma resonance). We need the data from the SubB2M ELISA test to be certain the same performance can be achieved. No point chucking out any technologies just yet from what i understand.
Ann: BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data, page-15
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
-0.025(4.50%) |
Mkt cap ! $59.10M | |||
| Open | High | Low | Value | Volume |
| 55.5¢ | 55.5¢ | 53.0¢ | $41.26K | 75.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1231 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 31027 | 2 |
View Market Depth
| Last trade - 15.46pm 10/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |